Physician profile
Daniela Caltaru
NPI 1346234762
$788.95
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $634 · 2020: $134 · 2022: $20.77.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $205.58 | 2019-2020 | |
| Biogen, INC. | $61.00 | 2019-2020 | |
| Emd Serono, INC. | $58.50 | 2019 | |
| Vertical Pharmaceuticals, LLC | $57.07 | 2019 | |
| Amgen INC. | $54.58 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $51.98 | 2019 | |
| Novartis Pharmaceuticals Corporation | $51.51 | 2019-2020 | |
| Genzyme Corporation | $50.89 | 2019 | |
| Upsher-Smith Laboratories LLC | $37.40 | 2019 | |
| Allergan, INC. | $26.72 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $25.98 | 2019 | |
| Jazz Pharmaceuticals INC. | $24.93 | 2019 | |
| Lilly USA, LLC | $21.36 | 2019 | |
| Mdd US Operations, LLC | $20.77 | 2022 | |
| Neurocrine Biosciences, INC. | $16.09 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $13.53 | 2019 | |
| Sunovion Pharmaceuticals INC. | $11.06 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniela Caltaru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.